medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Risk of death by age and gender from CoVID-19 in Peru,
March-May, 2020

Authors: Cesar Munayco1,#, Gerardo Chowell2,#, Amna Tariq2, Eduardo A.
Undurraga3,4 , Kenji Mizumoto2,5,6*

Affiliations:
1

Centro Nacional de EpidemiologÃ­a, PrevenciÃ³n y Control de Enfermedades, Peruvian

Ministry of Health, Lima, Peru
2

Department of Population Health Sciences, School of Public Health, Georgia State

University, Atlanta, Georgia, USA
3

Escuela de Gobierno, Pontificia Universidad CatÃ³lica de Chile, Santiago, Region

Metropolitana, Chile
4

Millennium Initiative for Collaborative Research in Bacterial Resistance

(MICROB-R), Chile
5

Graduate School of Advanced Integrated Studies in Human Survivability, Kyoto

University Yoshida-Nakaadachi-cho, Sakyo-ku, Kyoto, Japan
6

Hakubi Center for Advanced Research, Kyoto University, Yoshidahonmachi,

Sakyo-ku,Kyoto, Japan.

#: These authors contributed equally
*: Corresponding author
1

NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Correspondence to:
K Mizumoto, Graduate School of Advanced Integrated Studies in Human Survivability,
Kyoto University Yoshida-Nakaadachi-cho, Sakyo-ku, Kyoto, Japan
Tel: +81 75 762 2001 Fax: +81 75 762 2277
E-mail: mizumoto.kenji.5a@kyoto-u.ac.jp

Article type: Research Articles
Word count:
Abstract: 199/200
Main: 2635

2

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Abstract
Peru implemented strict social distancing measures during the early phase of the
epidemic and is now experiencing one of the largest CoVID-19 epidemics in Latin
America. Estimates of disease severity are an essential indicator to inform policy
decisions about the intensity and duration of interventions needed to mitigate the
outbreak. Here we derive delay-adjusted case fatality rates (aCFR) of CoVID-19 in a
middle-income country in South America.
We used government-reported time series of CoVID-19 cases and deaths stratified by
age group and gender.
Our estimates as of May 25, 2020, of the aCFR for men and women are 10.8%
(95%CrI: 10.5-11.1%) and 6.5% (95%CrI: 6.2-6.8%), respectively, and an overall aCFR
of 9.1% (95%CrI: 8.9-9.3%). Our results show that senior individuals are the most
severely affected by CoVID-19, particularly men, with aCFR of almost 60% for those
aged 80- years. We found that men have a significantly higher cumulative morbidity
ratio than women across most age groups (proportion test, p-value< 0.001), with the
exception of those aged 0-9 years.

3

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

The COVID-19 epidemic is imposing a large mortality burden in Peru. Senior
individuals, especially those who are older than 70 years of age, are being
disproportionately affected by the COVID-19 pandemic.

Keywords: COVID-19, Peru, risk of death, time-delay adjusted CFR, 2020

4

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Introduction
As of May 25, 2020, more than 5.5 million CoVID-19 (illness caused by the novel
coronavirus SARS-COV-2) cases and ~340,000 deaths have been reported from almost
every country and territory around the globe [1, 2].

The CoVID-19 pandemic has

imposed a substantial burden on health systems, economies, and societies globally, and
there are strong indicators pointing to a disproportionate impact on low- and
middle-income countries [3-5]. Since its initial outbreak in China, the world has tracked
the CoVID-19 pandemic proliferating across Europe and Asia, seeding hotspots in
North America, and the Middle East [6]. The pandemic arrived late to South America;
Brazil reported its first case on February 26, 2020 [7]. Neighboring countries contracted
CoVID-19 cases in subsequent days; South America has registered more than 600,000
cases and 30,600 deaths as of May 24, 2020 [1]. Although many South American
countries imposed strict control measures, including travel bans, school closures, and
lockdowns early in the epidemic, the pandemic now rivals Europe in size, with
COVID-19 cases and death counts increasing rapidly [1, 5]. Other factors, including
high poverty rates, informal economies, inadequate water, sanitation, and hygiene
infrastructure, frail healthcare systems, and insufficient medical supplies, further

5

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

complicate the health and socioeconomic effects of the CoVID-19 pandemic [5, 8-10].
Governments in South America are now facing the social and economic consequences
of SARS-COV-2 containment measures, while struggling to the contain the virus [9].

Peru, a country of about 30 million people, is experiencing one of the largest CoVID-19
epidemics in Latin America. With an approximate two-fold increase in the cumulative
case count during the past two weeks, Peru has reported almost 129,148 cases and 7660
deaths as of May 25, 2020 [11]. The majority (63%) of COVID-19 cases have been
confirmed in Lima, the capital of Peru [11]. The government of Peru initiated social
distancing measures soon after the confirmation of the first imported case in Peru on
March 6, 2020 [12]. The initial epidemic control measures included school closures on
March 11, 2020 followed by the suspension of large gatherings and flights from Europe
and Asia the next day. Subsequently the government declared national emergency in the
country and closed country borders on March 16, 2020 [13]. Despite these forthcoming
and swift control measures, community transmission was reported to be occurring by
March 17, 2020, forcing the implementation of a night time curfew as of March 18,
2020 [13].

6

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Estimates from the early stage of the epidemic in Peru (March 2020) showed sustained
transmission in Lima with an estimated of reproduction number R~2.3 (95% CI: 2.0,
2.5) [14]. Moreover, the 20-days ahead forecast for Lima indicated that the prompt
social distancing measures have significantly slowed down the initial spread of the virus
in the region [14]. The crude case fatality rate (CFR), defined as the number of
cumulative deaths and cases at a single time point, in Peru is estimated at 5.9%,
approximating the global crude CFR average of ~6.3% [15]. Statistical analyses and
mathematical models using data from Peru suggest that under current epidemic growth,
the number of CoVID-19 infected individuals could surpass the healthcare system
capacity [16].

The clinical spectrum of CoVID-19 ranges from asymptomatic cases to clinical
conditions characterized by respiratory failure, to multiorgan and systemic
manifestations which can cause death [17-19]. CFR is a statistical entity used to
estimate severity of the epidemic [20] as it provides a criterion for the public health
officials to gauge the intensity and duration of public health interventions required to
contain the epidemic [21]. However, it becomes challenging to estimate CFR during an
epidemic as CFR estimates are sensitive to right censoring of the data that occurs
7

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

because of the time lag between the date of symptoms onset and the date of death for a
case [22-24]. Moreover, under-reporting of cases because mild or asymptomatic cases
can go undetected by disease surveillance systems also underestimates CFR [22, 25].

In this study we provide real-time estimates of adjusted age-specific CFR during the
CoVID-19 epidemic in Peru, through May 25, 2020 to assess the severity of the
SARS-CoV-2 epidemic in the region. The country has been performing PCR tests with
the average positivity rate estimated at ~8.6% as of March 30, 2020 [14]. In Peru ~85%
of ICU beds with ventilators are currently occupied by patients [26], therefore our
current estimates are not affected by excess deaths due to health care demand exceeding
health care capacity. However, fears of hospital overcrowding persist [26].

Results
As of May 25, a total of 129,148 cases and 7,660 deaths due to CoVID-19 have been
reported by the Ministry of Health, Peru. Among men, reported cases were mostly

8

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

observed among individuals aged 30-39 years (23.1%), followed by those aged 40-49
years (20.8%), and those aged 20-29 years (18.3%). In contrast, most deaths were
reported among those aged 50 years and above, especially among men aged 60-69
(29.3%) followed by those aged 70-79 (23.2%), aged 50-59 years (20.1%), and aged 80
years and above (14.3%). (Table 1, Figure 1A, 1B). Data show a similar pattern for
women. The majority of reported cases occur in females aged 20-69 years, and the
majority of reported deaths occur among women aged 50 years or more. More
specifically, most reported cases occur among women aged 30-39 (22.6%), followed by
women aged 40-49 (19.7%), and 50-59 year olds (16.0%). In contrast, most deaths are
reported among those aged 60-69 (30.2%), followed by women aged 70-79 (25.9%),
and lastly, women aged 80 years and above (18.4%). Regarding CoVID-19 mortality
per 100,000 population, seniors (individuals >70 years of age) were the most affected
age group; mortality burden per 100,000 is 279.2 among men aged 80 years and above,
and 207.6 among men aged 70-79 years. For women of 80 years of age or more
mortality is 108.8 and 85.1 for women aged 70-79 years (Table 1, Figure 1F).

The gender proportions of reported cases by age groups are presented in Figure 1C and
Figure 1D. The proportion of cases among men is higher than 50% across all age groups
9

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

(Ï‡2 test, p-value<0.001). Similarly, the proportion of male deaths is also higher than
50% except for those aged 10-19 years (Ï‡2 test, p-value<0.001). Cumulative morbidity
ratio by gender and age group is presented in Figure 1E, indicating that cumulative
morbidity ratio among men is higher than women across all age groups (proportion test,
p-value < 0.001) except for individuals aged 0-9 years (proportion test, p-value =0.85).
Figure 1F illustrates the mortality per 100,000 population directly caused by CoVID-19
by gender and age group. Mortality is higher than among females aged 20 years and
above (proportion test, p-value <0.05), and it is not significantly different among those
aged 0-19 years.

Figure 2 shows the cumulative cases and deaths of CoVID-19 by age group for males
and females (A through J) over time. The figure suggests cumulative deaths increases
after an increase in cumulative cases. The growth curve for overall cumulative cases (all
age groups) for men and women appears to increase exponentially until around day 60
(April 29th, 2020), while exponential growth in cumulative deaths overall (all age
groups) for men and women appears to occur until around day 70 (May 9th, 2020).

10

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 3 illustrates observed and model based posterior estimates of the crude CFR by
age group (A-J) and time-delay adjusted CFR by age group (K-T) for men and women.
Black dots show crude case fatality ratios, and light and dark indicate 95% and 50%
credible intervals (CrI) for posterior estimates, respectively.

Overall, our model based crude CFR fitted the observed data well, except for
individuals aged 80 years and above, probably influenced by low reporting
rate/ascertainment bias of cases at an early stage. Crude CFR for most of age groups
increased at the early stage of the epidemic, peaked amidst the outbreak ~day 34 (April
3rd, 2020) and followed a decreasing trend turning into an almost flat curve.

Overall, our model-based posterior estimates for the time-delay adjusted CFR are
substantially higher than the crude observed CFR. These estimates fluctuated at the
early stage of the epidemic and then followed a decreasing trend.

The most recent estimates, as of May 25, 2020, of the time-delay adjusted CFR for men
and women are 10.8% (95%CrI: 10.5-11.1%) and 6.5% (95%CrI: 6.2-6.8%),
respectively, while overall national estimate is 9.1% (95%CrI: 8.9-9.3%) (Figure 4 and
11

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Table 2). Among men, senior citizens appear to be severely affected; the adjusted CFR
is 33.1% (95%CrI: 31.7-34.6%) for men aged 60-69 years, 49.4% (95%CrI:
47.3-51.6%) for those aged 70-79 years, and 64.3% (95%CrI: 60.9-67.8%) for those 80
years old and above. We observe a similar pattern for women. The adjusted CFR is
19.2% (95%CrI: 17.9-20.6%) for women aged 60-69 years, 32.2% (95%CrI:
29.9-34.7%) for those aged 70-79 years, and 35.1% (95%CrI: 32.1-38.1%) for women
aged 80 years old or more.

Discussion
This study estimates the time-delay adjusted CFR by age group for the ongoing
CoVID-19 epidemic in Peru. The crude CFR varies across countries due to differences
in testing and timing of tests [27]. The results show that the CoVID-19 epidemic in Peru
disproportionately impacts senior individuals, especially those who are 70 years of age
or older, consistent with CFR estimates obtained from recent studies conducted in China
[28, 29], Chile [30], and Italy [31, 32]. This pattern, suggests that an aging population
could aggravate the fatality impact of CoVID-19, similar to influenza and respiratory
syncytial virus [30], as was probably the case in Italy [31, 32]. While the population in
12

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Lain America, including Peru, is aging at a rapid rate, still a relatively small percentage
of the population in the region are older than 65 years of age [33]. So in fact the age
structure in the region could favor a lower overall CFR than would be expected
otherwise with a relatively older population, as in other regions.

Our estimate of adjusted CFR among men (10.8% (95%CrI: 10.5-11.1%)) is 1.7-fold
higher than the estimated adjusted CFR for women (6.5% (95%CrI: 6.2-6.8%)),
consistent with the estimates given in ref [34]. Men aged 80 years or older have an
estimated adjusted CFR as high as 64.3% (95%CrI: 60.9-67.8%), 58-fold higher than
our estimates for men aged 0-9, and 1.3-fold higher than our estimates for men aged
70-79. Similarly, the adjusted CFR estimates for women of aged 80 years or older are as
high as 35.1% (95%CrI: 32.1-38.1%), 29-fold higher than the estimates obtained for
female aged 0-9 and 1.1-fold higher than the estimates obtained for female aged 70-79,
consistent with recent findings in Chile [30]. In comparison, a study conducted in China,
reported much lower estimates of CFR for individuals >80 years of age (13.4%) [29].

An upward trend in the crude CFR for overall population suggests the transmission may
be spreading to more vulnerable populations. The majority of social distancing
13

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

measures in Peru were implemented between March 11-March 18, 2020. However,
since 72.4% of the economically active population works in informal jobs, which are
concentrated in the poorest areas of the country, compliance with government
mitigation strategies can be challenging despite the governmentâ€™s efforts to support the
population [35]. Another factor possibly contributing to the upward trend in crude CFR
may be an increase in unreported cases due to saturated testing capacity [27]. However,
since Peruâ€™s testing capacity has substantially increased since the beginning of the
outbreak, going from >0.01 test per 1000 population to 0.09 per 1000 in May 22 [15],
and the positivity rate is estimated at ~8.6% as of March 30, 2020, this seems an
unlikely cause. Furthermore, the results show an increasing trend in crude CFR around
day 45 (May 14th, 2020), probably reflecting the exponential increase of cumulative
cases around day 40 (May 9th, 2020).

The downward trend in the adjusted CFR at the early stage may indicate the existence
of a reporting delay and the shift of the outbreak to a less vulnerable segment of the
population. In particular, the observed differences in estimates between the crude CFR
and adjusted CFR can be attributed to the time-delay that is assumed fixed during the
course of the epidemic.
14

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

The relatively small proportion of males (53.5%) among CoVID-19 cases in the
individuals aged 80 years and above can be attributed to the relatively small male
population size for that age group; with men comprising only 1.7% of the population
>80 years of age in Peru, consistent with estimates for Chile [30]. As higher mortality
among male has been reported in China and the U.S. [34], additional data on deaths
stratified by gender provides the opportunity to examine the CFR by gender and age.

Our study has at least two limitations. First, our estimates are probably overestimated,
due to the effect of under reporting rates and ascertainment rates, as has been
underscored in other studies [22, 24, 36]. But a recently enhanced testing capacity in
Peru is expected to mitigate these effects, and an ongoing mass serological study will
provide data to generate more accurate estimates of the death risk. Second, adjusted
CFR, especially among seniors, has displayed fluctuations, highlighting the importance
of focusing on sub-group analyses. Additional information such as line lists that include
related risks including information on underlying diseases may help to identify
subgroups with elevated risks.

15

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Conclusions
The COVID-19 epidemic is imposing a large death toll in Peru. Senior individuals,
especially those who are older than 70 years of age, are being disproportionately
affected by the COVID-19 pandemic, particularly elderly men. CFR was as high as
64.3% (95%CrI: 60.9-67.8%) for men aged 80 older, 58-fold higher than our estimates
for men aged 0-9. The overall adjusted CFR is larger than in other countries, which is
worrying, particularly because healthcare demand has not yet exceeded capacity, but
probably will do in the coming weeks. The relatively younger age structure in Latin
America may help ameliorate the overall CFR than would otherwise be expected with
an older age structure in the population.

Materials and methods
Data
We obtained daily cumulative numbers of reported laboratory confirmed CoVID-19
cases and deaths stratified by age group and gender through May 25, 2020. Different
age groups had different starting times, which correspond to the day when death was
reported. Confirmed CoVID-19 cases were retrieved from three surveillance systems: a)
16

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

national surveillance system (confirmed and suspected cases based on a case definition),
b) Netlab system (molecular test) and c) SICOVID system (rapid serological test).
COVID-19 deaths were obtained from two surveillance systems: a) national
surveillance system (confirmed and suspected deaths based on a case definition) and b)
Vital statistics system (National System of mortality -SINADEF- which is an online
system that keeps track of death certificates).
Population size by age, group, and gender in 2020 were retrieved from the Ministry of
Health in Peru [37]

Statistical analysis:
The crude CFR is defined as the number of cumulative deaths over the number of
cumulative cases. For the estimation of CFR in real time, we employed the delay from
hospitalization to death, hs, which is assumed to be given by hs = H(s) â€“ H(s-1) for s>0
where H(s) is a cumulative density function of the delay from hospitalization to death
and follows a gamma distribution with mean 10.1 days and SD 5.4 days, as given in ref,
Mizumoto and Chowell [21]. Let Ï€a,ti be the time-delay adjusted case fatality ratio on
reported day ti in area

, the likelihood function of the estimate  , is given by

equation:
17

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .



,

;  , , 

,











,

,  

,

,


âˆ‘
âˆ‘
  , 


âˆ‘  ,


âˆ‘
âˆ‘
  , 


âˆ‘  ,

âˆ‘

,



,

1

,

where ca,t represents the number of new cases with reported day t in area

, and  , is

the cumulative number of deaths until reported day ti in area a [38, 39]. Among the
cumulative cases with reported day t in area a,  , have died and the remainder have
survived the infection. The contribution of those who have died with biased death risk is
shown in the middle parenthetical term and the contribution of survivors is presented in
the right parenthetical term. We assume that  , is the result of the binomial sampling
process with probability  , .

We used a Monte Carlo Markov Chain (MCMC) method in a Bayesian framework to
estimate model parameters. We evaluated the convergence of MCMC chains using the
potential scale reduction statistic [40, 41]. Estimates and 95% credibility intervals for
these estimates are based on the posterior probability distribution of each parameter and
samples drawn from the posterior distributions. All statistical analyses were conducted
18

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

in R version 3.6.1 (R Foundation for Statistical Computing, Vienna, Austria) using the
â€˜rstanâ€™ package.

Acknowledgments
This work was supported by the Japan Society for the Promotion of Science (JSPS)
KAKENHI [grant Number 20H03940]; the Leading Initiative for Excellent Young
Researchers from the Ministry of Education, Culture, Sport, Science & Technology of
Japan to [KM]; National Science Foundation NSF [grant 1414374] as part of the joint
NSF-National Institutes of Health NIH-United States Department of Agriculture USDA
Ecology and Evolution of Infectious Diseases program; UK Biotechnology and
Biological Sciences Research Council [grant BB/M008894/1] to [GC]; and the ANID
Millennium Science Initiative/ Millennium Initiative for Collaborative Research on
Bacterial Resistance, MICROB-R, [NCN17_081] to [EU].

Author Contributions
GC and KM conceived the early study idea. KM implemented statistical analysis. AT
and KM wrote the first full draft. CM performed data acquisition. All authors
19

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

contributed to the revision of the manuscript. AU advised the study, and revised the
manuscript. GC advised on and helped shape the research. All authors contributed to the
interpretation of the results and edited and commented on several earlier versions of the
manuscript. All authors read and approved the final manuscript.

Conflict of interest
All authors report no conflicts of interest.

References
1.

Dong E, Du H and Gardner L. An interactive web-based dashboard to track

COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):P533-P534.

2.

World Health Organization. (2020). Coronavirus Disease (COVID-19)

Outbreak. (Geneva: WHO).

3.

World Bank. (2020). The Economy in the Time of CoVID-19. In: Bank W, ed.

Semiannual Report of the Latin America and Caribbean Region. (Washington DC:
World Bank).

20

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

4.

Lloyd-Sherlock P, Ebrahim S, Geffen L and McKee M. Bearing the brunt of

covid-19: older people in low and middle income countries. BMJ. 2020; 368:m1052.

5.

Burki T. COVID-19 in Latin America. Lancet Infect Dis. 2020; 20(5):547-548.

6.

Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C, Kobinger G, Lane

HC, Memish Z, Oh M-d, Sall AA, Schuchat A, Ungchusak K and Wieler LH.
COVID-19: towards controlling of a pandemic. The Lancet. 2020;
395(10229):1015-1018.

7.

Rodriguez-Morales AJ, Gallego V, Escalera-Antezana JP, MÃ©ndez CA,

Zambrano LI, Franco-Paredes C, SuÃ¡rez JA, Rodriguez-Enciso HD, Balbin-Ramon GJ,
Savio-Larriera E, Risquez A and Cimerman S. COVID-19 in Latin America: The
implications of the first confirmed case in Brazil. Travel Med Infect Dis. 2020; epub
ahead of print:101613.

8.

The Lancet. COVID-19: learning from experience. Lancet. 2020;

395(10229):1011.

9.

Navarro J-C, Arrivillaga-HenrÃ­quez J, Salazar-Loor J and Rodriguez-Morales

AJ. COVID-19 and dengue, co-epidemics in Ecuador and other countries in Latin
21

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

America: Pushing strained health care systems over the edge. Travel Med Infect Dis.
2020.

10.

Lorenz C, Azevedo TS and Chiaravalloti-Neto F. COVID-19 and dengue fever:

A dangerous combination for the health system in Brazil. Travel Med Infect Dis. 2020.

11.

MOH. (2020). Sala Situacional COVID-19 Peru.

12.

Aquino M and Garrison C. (2020). Peru records first confirmed case of

coronavirus, President Vizcarra says. Rueters.

13.

Explorer A. (2020). Coronavirus in Peru- the latest updates. (Amazon Explorer.

14.

Munayco CV, Tariq A, Rothenberg R, Soto-Cabezas GG, Reyes MF, Valle A,

Rojas-Mezarina L, Cabezas C, Loayza M, Chowell G, Garro DC, Vasquez KM, Castro
ES, et al. Early transmission dynamics of COVID-19 in a southern hemisphere setting:
Lima-Peru: February 29thâ€“March 30th, 2020. Infectious Disease Modelling. 2020;
5:338-345.

15.

Hasell J, Ortiz-Ospina E, Mathieu E, Ritchie H and Roser M. (2020). To

understand the global pandemic, we need global testing â€“ the Our World in Data
COVID-19 Testing dataset.

Our World in data.
22

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

16.

Rainisch G, Undurraga EA and Chowell G. A dynamic modeling tool for

estimating healthcare demand from the COVID19 epidemic and evaluating
population-wide interventions. Int J Infect Dis. 2020.

17.

Cascella M, Rajnik M, Cuomo A, Dulebohn SC and Napoli RD. Features,

Evaluation and Treatment Coronavirus (COVID-19). Stat pearls. 2020.

18.

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l,

Hui DSC, Du B, Li L-j, Zeng G, et al. Clinical Characteristics of Coronavirus Disease
2019 in China. N Engl J Med. 2020.

19.

Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling

BJ, Lipsitch M and Leung GM. Estimating clinical severity of COVID-19 from the
transmission dynamics in Wuhan, China. Nat Med. 2020.

20.

Carrie R, Matthew B, Lyn F, Lisa MK, Denise B, Amra U, Andrew P, Joe B,

Stephen CR and Daniel BJ. Novel Framework for Assessing Epidemiologic Effects of
Influenza Epidemics and Pandemics. Emerging Infectious Disease journal. 2013;
19(1):85.

23

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

21.

Mizumoto K and Chowell G. Estimating risk for death from 2019 novel

coronavirus disease, China, January-February 2020. Emerg Infect Dis. 2020;
26(6):10-3201.

22.

Li R, Pei S, Chen B, Song Y, Zhang T, Yang W and Shaman J. Substantial

undocumented infection facilitates the rapid dissemination of novel coronavirus
(COVID-19). Science. 2020; 368(6490):489-493.

23.

Jewell NP, Lei X, Ghani AC, Donnelly CA, Leung GM, Ho LM, Cowling BJ

and Hedley AJ. Non-parametric estimation of the case fatality ratio with competing
risks data: an application to Severe Acute Respiratory Syndrome (SARS). Stat Med.
2007; 26(9):1982-1998.

24.

Lipsitch M, Donnelly CA, Fraser C, Blake IM, Cori A, Dorigatti I, Ferguson

NM, Garske T, Mills HL and Riley S. Potential biases in estimating absolute and
relative case-fatality risks during outbreaks. PLoS Negl Trop Dis. 2015; 9(7).

25.

Wang C, Liu L, Hao X, Guo H, Wang Q, Huang J, He N, Yu H, Lin X and Pan

A. Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the
Outbreak of Coronavirus Disease 2019 in Wuhan, China. medRxiv. 2020.
24

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

26.

Castillo M. (2020). Peru seemed to do everything right. So how did it become a

Covid-19 hotspot? CNN.

27.

Asahi K, Undurraga EA and Wagner R. Benchmarking the CoVID-19

pandemic across countries and states in the U.S.A. under heterogeneous testing.
medRxiv. 2020:2020.2005.2001.20087882.

28.

Deng X, Yang J, Wang W, Wang X, Zhou J, Chen Z, Li J, Chen Y, Yan H,

Zhang J, Zhang Y, Wang Y, Qiu Q, et al. Case fatality risk of novel coronavirus
diseases 2019 in China. medRxiv. 2020.

29.

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N,

Cuomo-Dannenburg G, Thompson H, Walker PGT, Fu H, Dighe A, Griffin JT,
Baguelin M, et al. Estimates of the severity of coronavirus disease 2019: a model-based
analysis. Lancet Infect Dis. 2020; 20(6):P669-677.

30.

Undurraga EA, Chowell G and Mizumoto K. Case fatality risk by age from

COVID-19 in a high testing setting in Latin America: Chile, March-May, 2020.
medRxiv. 2020:2020.2005.2025.20112904.

25

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

31.

Onder G, Rezza G and Brusaferro S. Case-fatality rate and characteristics of

patients dying in relation to COVID-19 in Italy. Jama. 2020.

32.

Dowd JB, Andriano L, Brazel DM, Rotondi V, Block P, Ding X, Liu Y and

Mills MC. Demographic science aids in understanding the spread and fatality rates of
COVID-19. Proc Natl Acad Sci. 2020; 117(18):9696-9698.

33.

Ham-Chande R and Nava-BolaÃ±os I. Convergence Toward Demographic

Aging in Latin America and the Caribbean. Annu Rev Sociol. 2019; 45:607-623.

34.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson

KW, Barnaby DP, Becker LB, Chelico JD and Cohen SL. Presenting characteristics,
comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the
New York City area. JAMA. 2020; online first April 22.

35.

MartÃ­nez AD. (2020). Peru Passes Coronavirus Risk to the Working Class

(disponible en espaÃ±ol). (nacla

36.

Ghani AC, Donnelly CA, Cox DR, Griffin JT, Fraser C, Lam TH, Ho LM,

Chan WS, Anderson RM, Hedley AJ and Leung GM. Methods for Estimating the Case

26

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Fatality Ratio for a Novel, Emerging Infectious Disease. Am J Epidemiol. 2005;
162(5):479-486.

37.

Instituto Nacional de EstadÃ­stica e InformÃ¡ticas. PERÃš: Estimaciones y

Proyecciones de PoblaciÃ³n por Departamento, Sexo y Grupos Quinquenales de Edad
1995-2025.

BoletÃ­n de AnÃ¡lisis DemogrÃ¡fico No 37.

Lima, Setiembre 2009.

Aveilable from https://www.inei.gob.pe/media/principales_indicadores/libro_1.pdf

38.

Nishiura H, Klinkenberg D, Roberts M and Heesterbeek JA. Early

epidemiological assessment of the virulence of emerging infectious diseases: a case
study of an influenza pandemic. PLoS One. 2009; 4(8).

39.

Tsuzuki S, Lee H, Miura F, Chan YH, Jung S-m, Akhmetzhanov AR and

Nishiura H. Dynamics of the pneumonic plague epidemic in Madagascar, August to
October 2017. Eurosurveillance. 2017; 22(46).

40.

Gamerman D and Lopes HF. (2006). Markov chain Monte Carlo: stochastic

simulation for Bayesian inference: CRC Press).

41.

Gelman A and Rubin DB. Inference from iterative simulation using multiple

sequences. Stat Sci. 1992; 7(4):457-472.
27

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Table 1. Distribution of the cases by sex and age groups, as of May 25, 2020
Men

Age
group
All
0-9
10-19
20-29
30-39
40-49
50-59
60-69
70-79
80 -

Cases

Deaths

(%)
78264
(100)
1416
(1.8)
2475
(3.2)
14306
(18.3)
18052
(23.1)
16258
(20.8)
13274
(17.0)
7034
(9.0)
3620
(4.6)
1769
(2.3)

(%)
5508
(100)
10
(0.2)
8
(0.1)
32
(0.6)
169
(3.1)
499
(9.1)
1107
(20.1)
1615
(29.3)
1279
(23.2)
789
(14.3)

cCFR
(%)

Women
Mortality
per 100,000
population

7.0%

34.0

0.7

0.4

0.3

0.3

0.2

1.2

0.9

6.6

3.1

23.7

8.3

67.7

23.0

150.4

35.3

207.6

44.6

279.2

28

Cases

Deaths

(%)
50884
(100)
1362
(2.7)
2128
(4.2)
8707
(17.1)
11487
(22.6)
10005
(19.7)
8124
(16.0)
5023
(9.9)
2488
(4.9)
1536
(3.0)

(%)
2152
(100)
11
(0.5)
6
(0.3)
19
(0.9)
49
(2.3)
140
(6.5)
323
(15.0)
649
(30.2)
558
(25.9)
397
(18.4)

cCFR(%
)

Mortality
per 100,000
population

4.2

13.1

0.8

0.4

0.3

0.2

0.2

0.7

0.4

2.0

1.4

6.7

4.0

19.7

12.9

56.6

22.4

85.1

25.8

108.8

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Table 2. Summary results of time-delay adjusted case fatality ratio of COVID-19 in
each age group in Peru, 2020 as of May 25, 2020
Age
group
Overall

9.1% (95%CrIa: 8.9-9.3%)

Range of median
estimates
9.1-32.0%

Male

10.8% (95%CrI: 10.5-11.1%)

10.8-42.3%

Female

6.5% (95%CrI: 6.2-6.8%)

6.4-20.0%

Male

1.1% (95%CrI: 0.5-1.8%)

1.0-13.3%

Female

1.2% (95%CrI: 0.7-2.0%)

1.2-31.4%

Male

0.5% (95%CrI: 0.3-1.0%)

0.4-1.6%

Female

0.5% (95%CrI: 0.2-0.9%)

0.4-3.8%

Male

0.4% (95%CrI: 0.2-0.5%)

0.4-10.0%

Female

0.4% (95%CrI: 0.2-0.6%)

0.4-1.3%

Male

1.5% (95%CrI: 1.3-1.7%)

1.5-32.3%

Female

0.7% (95%CrI: 0.5-0.9%)

0.9-4.4%

Male

4.8% (95%CrI: 4.4-5.2%)

4.8-34.7%

Female

2.2% (95%CrI: 1.8-2.5%)

2.2-44.6%

Male

12.4% (95%CrI: 11.7-13.1%)

12.4-60.0%

Female

6.0% (95%CrI: 5.4-6.7%)

7.5-27.7%

Male

33.1% (95%CrI: 31.7-34.6%)

33.1-77.8%

Female

19.2% (95%CrI: 17.9-20.6%)

19.2-40.9%

Male

49.4% (95%CrI: 47.3-51.6%)

48.7-97.8%

Female

32.2% (95%CrI: 29.9-34.7%)

24.1-74.9%

Male

64.3% (95%CrI: 60.9-67.8%)

64.3-98.9%

Female

35.1% (95%CrI: 32.1-38.1%)

35.1-98.3%

0-9

10-19

20-29

30-39

40-49

50-59

60-69

70-79

80-

Gender

Latest estimate

29

Crude case fatality rate
5.9% (95%CIb: 5.8-6.1%)
7660/129148 c
7.0% (95%CI: 6.9-7.2%)
5508/78264
4.2% (95%CI: 4.1-4.4%)
2152/50884
0.7% (95%CI:0.3-1.3%)
10/1416
0.8% (95%CI: 0.4-1.4%)
11/1362
0.3% (95%CI: 0.1-0.6%)
8/2475
0.3% (95%CI: 0.1-0.6%)
6/2128
0.2% (95%CI: 0.2-0.3%)
32/14306
0.2% (95%CI: 0.1-0.3%)
19/8707
0.9% (95%CI: 0.8-1.1%)
169/18052
0.4% (95%CI: 0.3-0.6%)
49/11487
3.1% (95%CI: 2.8-3.3%)
499/16258
1.4% (95%CI: 1.2-1.6%)
140/10005
8.3% (95%CI: 7.9-8.8%)
1107/13274
4.0% (95%CI: 3.6-4.4%)
323/8124
23.0% (95%CI: 22.0-24.0%)
1615/7034
12.9% (95%CI: 12.0-13.9%)
649/5023
35.3% (95%CI: 33.8-36.9%)
1279/3620
22.4% (95%CI: 20.8-24.1%)
558/2488
44.6% (95%CI: 42.3-47.0%)
789/1769
25.8% (95%CI: 23.7-28.1%)
397/1536

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

a

95%CrI: 95% credibility intervals (CrI), b 95%CI: 95% confidence interval, c Cumulative cases over

cumulative deaths

30

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure Legends
Figure 1. Epidemiological characterization of COVID-19 in Peru, as of May 25, 2020
(A) Age distribution of reported cases by gender, (B) Age distribution of reported
deaths by gender. (C) Gender proportion of COVID-19 cases by age group, (D) Gender
proportion of COVID-19 deaths by age group, (E) Cumulative morbidity ratio by
gender and age group, (F) Mortality directly caused by COVID-19 by gender and age
group

Figure 2: Temporal distribution of cases and deaths by age group due to COVID-19,
March-May 2020, Peru.

Top: Male, cumulative cases, Second top: Male, cumulative cases, Second bottom:
Female, cumulative cases, Bottom: Female cumulative deaths

(A) aged 0-9, (B) aged

10-19, (C) aged 20-29, (D) aged 30-39, (E) aged 40-49, (F) aged 50-59, (G) aged 60-69,
(H) aged 70-79 ,(I) aged 80- and (J) Overall (all age groups). Day 1 corresponds to
March 1st in 2020.

31

medRxiv preprint doi: https://doi.org/10.1101/2020.06.14.20123315; this version posted June 16, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license .

Figure 3: Temporal variation of male and female risk of death by age group caused by
COVID-19, March-May 2020, Peru.
Upper two rows; Male risk of deaths, Lower two rows; Female risk of deaths
Observed and posterior estimated of crude case fatality ratio of (A) aged 0-39, (B) aged
40-49, (C) aged 50-59, (D) aged 60-69, (E) aged 70-79, (F) aged 80- , (G) all age groups and
time-delay adjusted case fatality ratio of (H) aged 0-39, (I) aged 40-49, (J) aged 50-59 , (K)
aged 60-69 , (L) aged 70-79, (M) aged 80-, (N) Overall (all age groups). Day 1 corresponds
to March 1st in 2020. Black dots show crude case fatality ratio, and light and dark indicates
95% and 50% credible intervals for posterior estimates, respectively.

Figure 4. Latest estimates of time-delay adjusted risk of death caused by COVID-19 by age
group and gender, March-May 2020, Peru.
Distribution of time-delay adjusted risk of death from the latest estimates (May 25, 2020) is
presented. Top to bottom: female aged 0-9, female aged 10-19, female aged 20-29, female
aged 30-39, female aged 40-49, female aged 50-59, female aged 60-69, female aged 70-79,
female aged 80 and over, female overall

32

